- Home
- NNVC vs PTN Comparison
NNVC vs PTN Comparison
Compare NNVC & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- PTN
- Stock Information
- Founded
- NNVC 2005
- PTN 1986
- Country
- NNVC United States
- PTN United States
- Employees
- NNVC N/A
- PTN N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- NNVC Health Care
- PTN Health Care
- Exchange
- NNVC Nasdaq
- PTN Nasdaq
- Market Cap
- NNVC 22.0M
- PTN 25.4M
- IPO Year
- NNVC N/A
- PTN 1993
- Fundamental
- Price
- NNVC $1.19
- PTN $1.06
- Analyst Decision
- NNVC Strong Buy
- PTN Strong Buy
- Analyst Count
- NNVC 1
- PTN 1
- Target Price
- NNVC $6.50
- PTN $17.00
- AVG Volume (30 Days)
- NNVC 622.6K
- PTN 570.9K
- Earning Date
- NNVC 02-12-2025
- PTN 02-13-2025
- Dividend Yield
- NNVC N/A
- PTN N/A
- EPS Growth
- NNVC N/A
- PTN N/A
- EPS
- NNVC N/A
- PTN N/A
- Revenue
- NNVC N/A
- PTN $2,384,113.00
- Revenue This Year
- NNVC N/A
- PTN N/A
- Revenue Next Year
- NNVC N/A
- PTN N/A
- P/E Ratio
- NNVC N/A
- PTN N/A
- Revenue Growth
- NNVC N/A
- PTN N/A
- 52 Week Low
- NNVC $1.01
- PTN $0.68
- 52 Week High
- NNVC $3.59
- PTN $5.65
- Technical
- Relative Strength Index (RSI)
- NNVC 33.37
- PTN 47.60
- Support Level
- NNVC $1.42
- PTN $1.06
- Resistance Level
- NNVC $1.65
- PTN $1.20
- Average True Range (ATR)
- NNVC 0.11
- PTN 0.14
- MACD
- NNVC -0.04
- PTN -0.01
- Stochastic Oscillator
- NNVC 13.21
- PTN 7.14
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.